Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

444
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
444
Renal Corpuscle01:20

Renal Corpuscle

6.5K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
6.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

704
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
704
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

446
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
446
Dialysis01:27

Dialysis

1.0K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.0K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

386
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
386

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Features and management of kidney manifestations of tuberous sclerosis complex: a real-world study in a Brazilian patient cohort.

BMC nephrology·2026
Same author

Trimethylamine N-oxide (TMAO) disrupts endothelial junction integrity through VE-cadherin Tyr658 phosphorylation in vitro.

Archives of toxicology·2026
Same author

Secondary hyperparathyroidism: what we know and what we are still learning.

Jornal brasileiro de nefrologia·2025
Same author

MicroRNAs and vascular damage in chronic kidney disease: advances and clinical implications.

Jornal brasileiro de nefrologia·2025
Same author

Brazilian Guidelines on evaluation and clinical management of Nephrolithiasis: Brazilian Society of Nephrology.

Jornal brasileiro de nefrologia·2025
Same author

Secondary hyperparathyroidism due to chronic kidney disease and access to clinical treatment and parathyroidectomy in Brazil: a nationwide survey.

Jornal brasileiro de nefrologia·2025

Related Experiment Video

Updated: Dec 17, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.6K

How do Uremic Toxins Affect the Endothelium?

Regiane Stafim da Cunha1, Andressa Flores Santos1, Fellype Carvalho Barreto2

  • 1Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.

Toxins
|June 25, 2020
PubMed
Summary

Uremic toxins damage blood vessels in chronic kidney disease (CKD) by disrupting cell junctions and activating inflammatory pathways. Targeting these toxins and pathways may offer new therapies for cardiovascular complications in CKD patients.

Keywords:
endothelial dysfunctionendotheliumuremic toxins

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.6K
Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

376

Related Experiment Videos

Last Updated: Dec 17, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.6K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.6K
Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

376

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiovascular Biology

Background:

  • Chronic kidney disease (CKD) is associated with endothelial dysfunction.
  • Uremic toxins accumulate in CKD, contributing to endothelial barrier damage and increased permeability.
  • Endothelial cell-cell junctions are compromised by uremic toxins.

Purpose of the Study:

  • To investigate the mechanisms by which uremic toxins induce endothelial dysfunction in CKD.
  • To identify key signaling pathways and molecular mediators involved in toxin-induced endothelial damage.
  • To explore potential therapeutic targets for mitigating cardiovascular risks in CKD.

Main Methods:

  • Analysis of endothelial cell structure and permeability.
  • Investigation of membrane protein interactions with uremic toxins.
  • Assessment of oxidative stress and activation of signaling pathways (AhR, NF-κB, MAPK).
  • Evaluation of proinflammatory and prothrombotic protein expression.
  • Study of endothelial microparticle formation and microRNA modulation.

Main Results:

  • Uremic toxins disrupt endothelial cell-cell junctions, increasing permeability.
  • Toxins activate signaling pathways, leading to oxidative stress.
  • Activation of AhR, NF-κB, and MAPK pathways results in overexpression of inflammatory and prothrombotic factors.
  • Uremic toxins induce endothelial microparticle formation and alter microRNA expression.

Conclusions:

  • Uremic toxins are key drivers of endothelial dysfunction in CKD.
  • The identified signaling pathways and molecular changes contribute to cardiovascular disease pathogenesis.
  • Targeting uremic toxins and their modulated pathways presents a promising therapeutic strategy for CKD patients.